. These observations clearly indicate calpain is indispensable physiologically; however, the specific physiological functions of calpains and the molecular mechanisms underlying their functions remain unclear.
The mammalian calpain family comprises products from 14 independent genes, and can be 
Gly-clustering hydrophobic domain (V). The C-terminal fifth EF-hand motifs in domains IV
and VI cannot bind Ca 2+ , and interact with each other to form the hetero-dimer. Domain IV is also reported to function in the recognition of substrates and regulatory molecules (16) (17) (18) .
In the absence of Ca 2+ , the protease domain (II) is separated into two subdomains, IIa and IIb, and residues in the catalytic triad are prevented from assuming the correct positions for hydrolysis.
The binding of Ca 2+ to domains IIa, IIb, III, IV, and VI induces conformational changes that allow domain II to form a single active domain (19) (20) (21) (22) (23) .
Previous analyses revealed that μCL and mCL show full activity in the absence of 30K if correctly folded (24) , and cells from 30K gene-deficient mice, which die at E10. 5-11.5, show neither detectable μ-or m-calpain activity nor detectable μCL or mCL protein, even though their mRNAs are expressed normally (7, 8) . These results indicated that 30K functions as a molecular chaperon in vivo, at least for μCL and mCL.
nCL-2/calpain 8, identified as a stomach-specific calpain, is a typical calpain with four domains (25) (see Fig. 3B ). nCL-2 is most similar to mCL (amino acid identities in the full-length protein and in domains II and IV are 61.5%, 73.4%, and 51.8%, respectively). Possible functions for nCL-2 in the pituitary gland and in the embryogenesis of Xenopus laevis have been reported (26, 27) . We recently showed that, in the stomach, nCL-2 as well as nCL-4/calpain 9, a digestive tract-specific calpain, are expressed specifically in the mucus-secreting pit cells, quite unlike the μ-and m-calpains, which are expressed diffusely in all cells, and that nCL-2 may be involved in the regulation of vesicle trafficking in the gastric surface mucus cells (pit cells) (28) .
These reports highlight potentially important nCL-2 functions that cannot be compensated for by μ-and m-calpains, not only in the stomach but also in other tissues.
However, the enzymatic properties of nCL-2, including its regulatory mechanisms, have not been reported, except for one yeast two-hybrid analysis suggesting that nCL-2 does not interact with 30K despite the high similarity between nCL-2 and mCL (29) . Thus, in this study, using E.
coli-expressed and purified nCL-2, the detailed biochemical properties of this enzyme were examined, and several unique characteristics were revealed. Unexpectedly, nCL-2 was found to exist as both a monomer and as homo-oligomers, and the domain responsible for oligomerization was, unlike in the μ-and m-calpains, the C2-like domain (III), not the PEF domain (IV), suggesting that nCL-2 has a novel regulatory mechanism.
Experimental Procedures
Materials-Recombinant human μ-and m-calpains, anti-nCL2 polyclonal antibody (previously called anti-nCL2/2'), and mouse gastric mucosal protein were prepared as described previously (28, 30 For COS7 cell expression, the amplified cDNAs were ligated into a modified pSRD vector (31) to produce proteins fused with an N-terminal FLAG, HA, or myc-tag. The nCL-2 deletion mutants were constructed by introducing termination codons at the appropriate positions using a PCR-mediated site-directed mutagenesis method as previously described (10) .
Protein expression in bacterial cells and purification-
The constructed pCold I expression plasmids were transformed into E. coli BL21/pG-Tf2 (TaKaRa), and the transformants were cultured at 37°C in 3 L of LB medium containing 0.1 mg/ml ampicillin until A 600 = 0.6. coli culture, and subjected to further analyses.
Enzymatic properties of recombinant nCL-2.
Using the nCL-2 prepared above, the enzymatic (Fig. 1B) . Furthermore, "mock purification" was also performed using the mock-transformed cell lysate (Fig. 1C, S2 ) in the same manner as that for WT nCL-2 (Fig. 1C, S1 ).
As a result, the final Mono Q fractions (Fig. 1C, lanes E1-E3) around 0.2 M NaCl, where WT nCL-2 was mainly eluted, showed no activity.
Thus, the possibility of host protease activities was excluded.
The optimal temperature for nCL-2 activity was 20°C (Fig. 2C) , which was similar to that for μ-and m-calpain under our assay conditions, and to that reported previously for nCL-4 (32,33). The time courses of nCL-2 activity at various temperatures showed that the initial rates were maximal at 30 to 37°C, while maximal activity was achieved at 15°C (Fig. 2D) . The low optimal temperature for nCL-2 indicates that it is unstable at higher temperatures in the presence of Ca
2+
. The optimal pH for nCL-2 activity was 6.0, which is lower than the optimal pHs for conventional calpains (Fig. 2E ).
Autolytic properties of nCL-2. The autolysis of nCL-2 was examined by SDS-PAGE analysis,
as shown in Fig. 3A . Various breakdown products appeared in a time-dependent manner, and were confirmed to be autolytic fragments of nCL-2 by western blot analysis (Fig. 3B) . By N-terminal sequencing of a 43-kDa fragment (Fig. 3A , arrowhead e), one of the autolysis sites was determined to be between Ala-5 and Ala-6. Given its molecular weight, the C-terminus of this fragment was in or near the acidic loop in domain III (Fig. 3C, e) . When a tagged EF-5 deletion mutant (Fig. 4B , FLAG-or HA-ΔEF5) was co-expressed with full-length nCL-2 or its ΔEF5 mutant, the ΔEF5 mutant was co-precipitated with the ΔEF5 mutant as well as with full-length nCL-2 (Fig. 4F , lanes 6-8; Table 1 ), indicating that EF-5 is not required for the homo-oligomerization of nCL-2.
Therefore, to identify the novel domain(s)
critical for the homo-oligomer formation, domain IV-and domain III/IV-truncated mutants (Fig. 4B , ΔdIV and ΔdIII+IV, respectively) were tested. The
ΔdIV mutant was co-precipitated with the ΔdIV mutant ( 5A & B; Table 1 ). These results strongly suggest that nCL-2 oligomerizes through domain III, and that domain I and/or II may also be required for the proper conformation for binding ( Table 1) .
Effect of oligomerization on nCL-2 activity.
To examine the effect of homo-oligomer formation on nCL-2 autolysis, HA-nCL-2 was co-expressed with FLAG-nCL-2, immunoprecipitated using an anti-FLAG antibody, and incubated in the absence or presence of Ca
2+
, followed by western blot analysis using anti-FLAG or anti-HA antibodies.
As shown in Fig. 6A , both FLAG-nCL-2 and HA-nCL-2 showed Ca 2+ -dependent autolysis in the same manner.
Next, to investigate whether or not Ca .
No interaction of nCL-2 with 30K-2.
Recently, 30K-2/CAPNS2, a novel small subunit that shares about 70% amino acid identity with 30K, was identified, and E. coli-expressed 30K-2 was shown to form a hetero-dimer with mCL that had enzymatic properties similar to m-calpain (mCL+30K) (35, 36) . Therefore, it was possible that 30K-2 interacts with and functions as a regulator of nCL-2. When FLAG-30K-2 was expressed in combination with HA-nCL-2 or HA-mCL, HA-mCL but not HA-nCL-2 was co-precipitated with FLAG-30K-2 (Fig. 7, lanes 3 and 6). The interaction of 30K-2 and mCL was weaker than that of 30K and mCL, consistent with previously reported results (35) .
DISCUSSION
In this study, we purified E. coli-expressed recombinant stomach-specific calpain, nCL-2, and demonstrated that it can be present as a monomer or form a homo-oligomer through domain III. This is the first description of the enzymatic and biochemical properties of nCL-2.
As expected from the high sequence similarity between nCL-2 and mCL, several enzymatic properties of nCL-2 resembled those of m-calpain, such as the Ca
2+
-dependency and the inhibitor profile of its enzyme activity. However, several other properties were unique to nCL-2, which might reflect its specific expression and functions in the stomach that cannot be compensated for by the μ-and m-calpains. First, nCL-2 showed a low optimal temperature in a long incubation assay, which was similar to that of nCL-4 (33) but different from that of p94Δ (37) . Second, the optimal pH for nCL-2 activity was lower than that for the μ-and m-calpains. These properties suggest that nCL-2 evolved to adapt to stomach-specific conditions. Alternatively, these findings may suggest the existence of certain
as-yet unidentified stabilizing factor(s) specific for nCL-2 in the stomach.
The specific activity of nCL-2 was much lower than the specific activities of the μ-and m-calpains. The strong autolytic activity (see Fig.   3A ), however, indicated that the low specific activity was not due to partial denaturation of the purified recombinant nCL-2. Moreover, the nCL-2 autolysis was very rapid and extensive; i.e., full-length nCL-2 decayed with a t1/2 of less than 10 sec at 25°C, and it was extensively degraded within 3 min (see Fig. 3A ). These properties are cells. The cell lysates were immunoprecipitated with anti-FLAG agarose and subjected to western blot analysis using anti-FLAG and anti-HA antibodies. 
